[go: up one dir, main page]

GT199800063A - Carprofeno selectivo para cox-2, para el tratamiento del dolor e inflamacion en perros. - Google Patents

Carprofeno selectivo para cox-2, para el tratamiento del dolor e inflamacion en perros.

Info

Publication number
GT199800063A
GT199800063A GT199800063A GT199800063A GT199800063A GT 199800063 A GT199800063 A GT 199800063A GT 199800063 A GT199800063 A GT 199800063A GT 199800063 A GT199800063 A GT 199800063A GT 199800063 A GT199800063 A GT 199800063A
Authority
GT
Guatemala
Prior art keywords
dogs
inflammation
pain
treatment
carprophen
Prior art date
Application number
GT199800063A
Other languages
English (en)
Inventor
Kristin Marie Lundy
Anthony Paul Ricketts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT199800063A publication Critical patent/GT199800063A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE AL TRATAMIENTO DEL DOLOR Y DE LA INFLAMACION EN PERROS, CON AGENTES ANTIINFLAMATORIOS QUE SON FARMACOS ANTIINFLAMATORIOS NO ESTEROIDEOS (NSAID) Y, EN PARTICULAR, A AGENTES TALES QUE TIENEN UNA MENOR INCIDENCIA DE EFECTOS SECUNDARIOS GASTROINTESTINALES ADVERSOS, YA QUE TALES EFECTOS SECUNDARIOS SON UN PROBLEMA PREVALENTE Y POTENCIALMENTE GRAVE EN LOS PERROS. ESTOS COMPUESTOS TIENEN LA ESTRUCTURA QUIMICA (I), EN LA QUE R2, R6 Y R9, SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTE.
GT199800063A 1997-05-05 1998-05-04 Carprofeno selectivo para cox-2, para el tratamiento del dolor e inflamacion en perros. GT199800063A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4563597P 1997-05-05 1997-05-05

Publications (1)

Publication Number Publication Date
GT199800063A true GT199800063A (es) 1999-10-26

Family

ID=21939053

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199800063A GT199800063A (es) 1997-05-05 1998-05-04 Carprofeno selectivo para cox-2, para el tratamiento del dolor e inflamacion en perros.

Country Status (32)

Country Link
EP (1) EP0988034A1 (es)
JP (1) JP2000513020A (es)
KR (2) KR20010012300A (es)
CN (1) CN1255059A (es)
AP (1) AP9801234A0 (es)
AR (2) AR011726A1 (es)
AU (1) AU6932198A (es)
BG (1) BG103852A (es)
BR (1) BR9808720A (es)
CA (1) CA2288759A1 (es)
DZ (1) DZ2479A1 (es)
EA (1) EA003696B1 (es)
GT (1) GT199800063A (es)
HR (1) HRP980244A2 (es)
HU (1) HUP0001286A3 (es)
ID (1) ID21311A (es)
IL (1) IL132570A0 (es)
IS (1) IS5220A (es)
MA (1) MA26491A1 (es)
NO (1) NO995389L (es)
NZ (1) NZ500183A (es)
OA (1) OA11213A (es)
PA (1) PA8450601A1 (es)
PE (1) PE72599A1 (es)
PL (1) PL337003A1 (es)
SK (1) SK148199A3 (es)
TN (1) TNSN98059A1 (es)
TW (1) TW590773B (es)
UY (1) UY24989A1 (es)
WO (1) WO1998050033A1 (es)
YU (1) YU55899A (es)
ZA (1) ZA983722B (es)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245797B1 (en) 1997-10-22 2001-06-12 Merck & Co., Inc. Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease
AU2003204888B2 (en) * 1998-05-22 2005-07-28 Pfizer Products Inc. Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives
US6506785B2 (en) * 1998-05-22 2003-01-14 Pfizer, Inc. Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives
WO2000024393A1 (en) * 1998-10-23 2000-05-04 Merck Frosst Canada & Co. Combination product comprising an e-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use
DE60023119T2 (de) * 1999-03-10 2006-07-20 G.D. Searle Llc Zusammensetzungen zur verabreichung eines cyclooxygenase-2-hemmers an tiere
AU1592901A (en) * 1999-11-11 2001-06-06 Eli Lilly And Company Oncolytic combinations for the treatment of cancer
WO2001087343A2 (en) * 2000-05-15 2001-11-22 Merck Frosst Canada & Co. Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
EA011309B1 (ru) 2000-06-13 2009-02-27 Вайет Составы для ослабления боли, содержащие целекоксиб
DE10032132A1 (de) * 2000-07-01 2002-01-17 Lohmann Therapie Syst Lts Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung
ATE421595T1 (de) 2000-08-07 2009-02-15 Univ Vanderbilt Zusammensetzungen und verfahren zum nachweis und zur quantifizierung von cox-2-aktivität und 2- arachidonylglycerin-metaboliten
AU2002354901A1 (en) * 2001-07-16 2003-03-03 Edward Hogestatt Compounds with analgesic, antipyretic and/or anti-inflammatory activity
EP1534305B9 (en) 2003-05-07 2007-03-07 Osteologix A/S Treating cartilage / bone conditions with water-soluble strontium salts
BRPI0412581A (pt) * 2003-07-31 2006-09-19 Pharmacia & Upjohn Co Llc formulação dispersável de um agente antiinflamatório
EP1940380A2 (en) * 2005-05-20 2008-07-09 Pfizer Limited Synergistic combinations of non-steroidal antiinflammatory drugs with alpha-2 delta-ligands
CN103120653B (zh) 2007-04-04 2015-09-30 希格默伊德药业有限公司 一种口服药物组合物
US8951570B2 (en) 2007-04-26 2015-02-10 Sigmoid Pharma Limited Manufacture of multiple minicapsules
PL2471518T3 (pl) 2009-05-18 2018-01-31 Sigmoid Pharma Ltd Kompozycja zawierająca kropelki oleju
BR112012002963A2 (pt) 2009-08-12 2017-10-24 Sigmoid Pharma Ltd composições imunomoduladoras compreendendo uma matriz de polímero e uma fase oleosa
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
US12109218B2 (en) 2014-12-09 2024-10-08 Aratana Therapeutics, Inc. Compositions of grapiprant and methods for using the same
PL3113774T3 (pl) 2014-03-06 2022-06-13 Elanco Animal Health Incorporated Kompozycje grapiprantu i sposoby ich zastosowania
PL3215127T3 (pl) 2014-11-07 2021-05-17 Sublimity Therapeutics Limited Kompozycje zawierające cyklosporynę
CN107106536A (zh) * 2015-01-09 2017-08-29 美洲豹动物健康公司 治疗伴侣动物的腹泻的方法
US20230174485A1 (en) * 2020-03-25 2023-06-08 Sri International Lipoxygenase inhibitors
US11116737B1 (en) 2020-04-10 2021-09-14 University Of Georgia Research Foundation, Inc. Methods of using probenecid for treatment of coronavirus infections
KR102404883B1 (ko) 2020-11-30 2022-06-07 (주)이노보테라퓨틱스 벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3896145A (en) * 1972-07-24 1975-07-22 Hoffmann La Roche Carbazoles
CA1319886C (en) * 1987-02-03 1993-07-06 Alberto Ferro Mixed micelle solutions

Also Published As

Publication number Publication date
CA2288759A1 (en) 1998-11-12
PA8450601A1 (es) 2000-05-24
WO1998050033A1 (en) 1998-11-12
DZ2479A1 (fr) 2003-02-01
HUP0001286A3 (en) 2000-12-28
NZ500183A (en) 2002-04-26
TW590773B (en) 2004-06-11
AU6932198A (en) 1998-11-27
HUP0001286A2 (hu) 2000-11-28
EP0988034A1 (en) 2000-03-29
BR9808720A (pt) 2000-07-11
KR20040004406A (ko) 2004-01-13
MA26491A1 (fr) 2004-12-20
HRP980244A2 (en) 1999-02-28
NO995389D0 (no) 1999-11-04
CN1255059A (zh) 2000-05-31
YU55899A (sh) 2003-08-29
SK148199A3 (en) 2001-09-11
NO995389L (no) 2000-01-04
AR011726A1 (es) 2000-08-30
EA199900895A1 (ru) 2000-06-26
AP9801234A0 (en) 1999-11-04
UY24989A1 (es) 2001-10-25
PE72599A1 (es) 1999-08-12
BG103852A (en) 2000-06-30
TNSN98059A1 (fr) 2005-03-15
AR039628A2 (es) 2005-03-02
JP2000513020A (ja) 2000-10-03
KR20010012300A (ko) 2001-02-15
PL337003A1 (en) 2000-07-31
IS5220A (is) 1999-10-19
ID21311A (id) 1999-05-20
EA003696B1 (ru) 2003-08-28
OA11213A (en) 2003-07-14
ZA983722B (en) 1999-11-04
IL132570A0 (en) 2001-03-19

Similar Documents

Publication Publication Date Title
GT199800063A (es) Carprofeno selectivo para cox-2, para el tratamiento del dolor e inflamacion en perros.
GT199600051A (es) Metanolsulfonato de (1s, 2s)-1- (4-hidroxifenil)-2-(4-hidroxi-4- fenilpiperidin-1-il)-1-propanol trihidrato.
GT199800021A (es) Utilizacion de antagonistas de los receptores de canabinoides centrales para la preparacion de medicamentos.
ES2176322T3 (es) Nuevos peptidos opioides para el tratamiento de dolores y su utilizacion.
GT199800171A (es) Inhibidores selectivos directos o indirectos del factor xa.
GT199700141A (es) Prevencion de la perdida y restauracion de la masa osea por determinados agonistas de prostaglandinas.
GT200100211AA (es) Compuestros de imidazol condensado con arilo o heteroarilo como agentes anti-inflamatorios y analgesicos. (patentefraccionaria no. 1 de la solicitud de patente de invencion no. pi-2001-0211.
CL2008003941A1 (es) Uso de escitalopram o de una sal farmaceuticamente aceptable del mismo para preparar un medicamento util en el tratamiento del desorden compulsivo obsesivo.
GT199700089A (es) Derivados 6.6 o 6.7 -biciclicos sustituidos que contienen pirido o pirimido.
ECSP055840A (es) Derivados de 4 -tetrazolil-4fenilpiperidina para el tratamiento del dolor
ES2194536T3 (es) Combinacion de duloxetina con farmacos antiinflamatorios no esteroideos.
ES2194392T3 (es) Derivados alfa-aminoamidicos utiles como agentes analgesicos.
UY27511A1 (es) Nuevos agentes andidiabéticos
CL2004000674A1 (es) Sistema terapeutico transdermico que comprende al menos una sustancia activa farmaceutica, al menos un disruptor de la estructura y/o al menos un formador de estructura en una matriz comun.
NO331819B1 (no) Hurtigdispergerende fast terapeutisk doseringsform
BG66093B1 (bg) Състави с контролирано освобождаване, съдържащи нимесулид
CY1112738T1 (el) Μια συνδυασμενη συνθεση που περιεχει ιβουπροφαινη και παρακεταμολη
UY27296A1 (es) Composición farmacéutica que contiene mosaprida y pancreatina
ES2171933T3 (es) Derivados de androsteno.
ECSP066575A (es) Antagonistas del receptor b1 de bradiquinina
PT770384E (pt) Composicoes farmaceuticas solidas anidras para utilizacao vaginal
AR012217A1 (es) Una composicion topica para mejorar la penetracion de compuestos farmaceuticos
TR200201071T2 (tr) Rar selektif retinoid antagonistleri kullanılarak anfizem tedavisi
AR021690A1 (es) Empleo de inhibidores del canal de ktq1 para la preparacion de un medicamento para el tratamiento de enfermedades, que son provocadas por helmintos yectoparasitos.
AR030957A1 (es) Composiciones de analgesico y glucosamina